Liver Transplantation

Article	Citations
CON: It’s time for new strategies to optimize liver transplant immunosuppression	75
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	51
Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen	51
Early living donor liver transplantation for alcohol-associated hepatitis: Status in the era of increasing demand, unmet needs, and future considerations	41
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	41
	41
CON: All patients should not receive a palliative care consult during LT evaluation	40
Development of posttransplant diabetes mellitus in US recipients of liver transplant is influenced by OPTN region	39
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	39
Recompensation of cirrhosis in candidates of transplant: Tips and tricks for delisting	37
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	36
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	35
Letter to the Editor: Survey of attitudes and knowledge of early paracentesis guidelines and performance in providers in the Veterans Health Administration	33
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	32
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	32
Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study	32
Acute liver failure: Do we have a consensus regarding management?	31
Breathing new life to posttransplant survival models	30
Quantitative methods for optimizing patient outcomes in liver transplantation	29
2024 Reviewers (Volume 30)	29
An international, multicenter, survey-based analysis of practice and management of acute liver failure	29
Issue Information ‐ Instructions to Authors	28
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	28
Issue Information ‐ Author Checklist	27
Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein	26

“Winning the peace” against obesity in recipients of liver transplant	26
Letter to the Editor: Technical advances in living donor liver transplantation: Maintaining a view of both donor and recipient outcomes	25
Anonymous Nondirected Living Liver Donation: Has the Time Come to Formalize the Process?	25
Sarcopenic obesity may predict worse liver regeneration after right graft living donor liver transplantation	25
Issue Information	23
Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion	23
Issue Information	22
Beware of Portal Vein Thrombosis After Laparoscopic Sleeve Gastrectomy in Liver Transplant Recipients	22
Letter to the Editor: Long-term experience in treating autoimmune hepatitis with acute presentation	22
Letter to the Editor: Can sexagenarian donors be feasibly indicated for living donor liver transplantation?	21
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	21
Donor-derived disorders of hemostasis and thrombosis in liver transplantation: Considerations for deceased donor liver selection	21
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	21
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	21
Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants	21
Reply	20
Exploring the lower weight limit of splitable liver grafts for pediatric recipients	20
High time for common ground in the assessment of steatosis	20
What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model	20
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	20
ILTS Annual Congress 2024 Abstracts	20
Issue Information ‐ Instructions to Authors	20
Hypothermic oxygenated machine perfusion as a tool to facilitate liver transplantation in the acute‐on‐chronic liver failure scenario	20
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	20
Measurements matter: Assessing outcomes in “lean” patients with nonalcoholic fatty liver disease awaiting liver transplantation	19
Protein induced by vitamin-K absence II: Another key to create a common language	19
CAQ Corner: Disease recurrence after liver transplantation	19
Empowering liver transplantation: The role of minimally invasive hepatectomy in advancing living donation	19
Issue Information	19
Disparities in travel time to liver transplantation centers in the United States	18
Issue Information ‐ Instructions to Authors	18
Deceased donor selection and management	18
Distal Gastroduodenal Arterial Inflow as a Salvage Strategy for Extensive Intraoperative Arterial Dissection in Living Donor Liver Transplantation	18
Unseen foe: The financial toxicity of liver transplantation	18
Issue Information ‐ Instructions to Authors	18
Reply: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	18
Pregnancy Outcomes After Living Liver Donation: A Multi‐Institutional Study	18
Gastrointestinal Infection and Liver Injury Are the Risk Factors for Coronavirus Disease 2019 Inpatients With Assisted Ventilation	17
Affordable Care Act Medicaid expansion associated with increased liver transplant waitlist access without worsening mortality	17
Experience With Moxifloxacin for the Treatment of Latent Tuberculosis Infection in Liver Transplantation: A Single‐Center Prospective Study	17
Prediction of long‐term morbidity and mortality after liver transplantation using two‐dimensional shear wave elastography compared with liver biopsy	17
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	17
Liver transplant evaluation redux: Hope for reconsidering previously declined candidates with alcohol-associated liver disease	17
Alpha‐fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha‐fetoprotein at liver transplantation	17
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients	17
Does liraglutide alleviate inflammation in brain-dead donors? A randomized clinical trial	17
Pediatric liver transplant recipients are not just young adults: The importance of a structured health care transition program in adult transplant centers	16
Utility of Preoperative Computed Tomography–Based Body Metrics in Relation to Postoperative Complications in Pediatric Liver Transplantation Recipients	16
Reply: Blocked drain switch—hepatic venous outflow obstruction	16
Reply: The urgent need for consensus around organ donation after assisted dying	16

Active coping, resilience, post-traumatic growth, and psychiatric symptoms among early and late liver transplant survivors	15
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	15
The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single‐Center Analysis	15
Long-term instead of repetitive treatment: benefits of primary stenting for portal vein stenosis in pediatric liver transplantation	15
Maximizing outcomes by donor-recipient age matching in liver transplantation	15
Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss	15
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population	15
Adenosine Diphosphate and the P2Y13 Receptor Are Involved in the Autophagic Protection of Ex Vivo Perfused Livers From Fasted Rats: Potential Benefit for Liver Graft Preservation	15
Chronic Kidney Disease After Simultaneous Liver‐Kidney Transplantation: Refining Patient Selection	15
Sleep disturbances in chronic liver disease	15
Seeking Editor for Hepatology Communications	14
The Evaluation of Cirrhotic Cardiomyopathy in Liver Transplantation Candidates: An Emerging Debate	14
Operationalizing multidisciplinary liver tumor boards for hepatocellular carcinoma	14
Issue Information ‐ Author Checklist	14
Postoperative fibrinolytic resistance is associated with early allograft dysfunction in liver transplantation: A prospective observational study	14
Unlocking metabolic flexibility: Is this the key to preventing weight gain in liver transplant recipients?	14
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	14
Comparison of pure laparoscopic donor right posterior sectionectomy versus right hemihepatectomy for living donor liver transplantation	14
Outcomes of Kidney Allograft and Recipient Survival After Liver Transplantation by Induction Type in the United States	14
Equivalence of the adapted electronic Pediatric Liver Transplant Quality of Life (PeLTQL) questionnaire: A patient-reported outcome measure for children and teens	14
Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols	13
The BIG question: Can we stop the use of HBIG?	13
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	13
Novel approaches are needed to study social determinants of health in liver transplantation	13
Portopulmonary hypertension practice patterns after liver transplantation	13
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	13
Impact of acuity circles on racial and ethnic disparities in liver transplantation	13
PRO: How satellite clinics can improve access to liver transplantation	13
Outcome of living donor liver transplantation for patients older than 70 years, with respect to preserved performance status and graft quality	13
Letter to the Editor: Aberrant arteries—1 may be better than 2 for the liver, but maybe not the bile duct	13
Proceedings of the 28th Annual Congress of the International Liver Transplantation Society	12
CAQ Corner: The practical assessment and management of sarcopenia, frailty, and malnutrition in patients with cirrhosis	12
The Unlimited Possibilities for Qualitative Research in Liver Transplantation	12
Issue Information ‐ Author Checklist	12
Reply: Stapled cavo-cavostomy in liver transplantation—Well-known tools in a new technique	12
Sixty years of functional clotting assays in pediatric liver transplantation	12
Liver Transplantation in Short Telomere‐Mediated Hepatopulmonary Syndrome Following Bone Marrow Transplantation Using HCV Positive Allografts: A Case Series	12
Reply	12
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	12
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic	12
The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: Alignment with Liver Imaging Reporting and Data System, current gaps, and future direction	11
Left Lobe Living Donor Graft Could Be a Good Choice for Liver Transplantation	11
Current Quandaries in the Management of Congenital Portosystemic Shunts	11
Hepatic steatosis after liver transplantation: a systematic review and meta-analysis	11
Early Survivorship After Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From the Patient and Caregiver Perspective	11
Indocyanine green fluorescence quantification during normothermic ex situ perfusion for the assessment of porcine liver grafts after circulatory death	11
Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation	11
An extensive evaluation of hepatic markers of damage and regeneration in controlled and uncontrolled donation after circulatory death	11
Intranodal Sirolimus Induces Regulatory T Cells in Human Hepatic Lymph Nodes via Interleukin 10 Signaling	11
Risk Factors for Posttransplantation Mortality in Recipients With Grade 3 Acute‐on‐Chronic Liver Failure: Analysis of a North American Consortium	11
Cost‐Effectiveness of Primary Liver Transplantation Versus Hepatoportoenterostomy in the Management of Biliary Atresia in the United States	11
Issue Information	11
Making the best use of testing for blood phosphatidylethanol	11
Reconstruction of all hepatic arteries in right lobe grafts with 2 hepatic arteries and zero percent hepatic artery thrombosis	11
Issue Information	11
Semaglutide is effective in achieving weight loss in liver transplant recipients	10
Reply	10
Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion Versus Donation After Brain Death Donors	10
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	10
Prolonged time from cross clamp until normothermic machine perfusion start is associated with increased risk of early allograft dysfunction following DCD liver transplant	10
Anonymity: What does it mean and why is it important to anonymous living liver donors?	10
Viscoelastic Monitoring in Liver Transplantation	10
Issue Information	10
Burnout Among Transplant Hepatologists in the United States	10
PRO: Patients with acute-on-chronic liver failure should receive MELD exception points	10
Seeking Editor for Clinical Liver Disease	10
The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach	10
Implications and Management of Cirrhosis‐Associated Immune Dysfunction Before and After Liver Transplantation	10
Combination of Donor Anthropometrics With Recipient Imaging to Improve Matching in Liver Transplantation	10
Improved outcomes of ABO-incompatible living donor liver transplant with biologically related donors	10
Best Practices in Large Database Clinical Epidemiology Research in Hepatology: Barriers and Opportunities	9
Issue Information ‐ Instructions to Authors	9
The Prognostic Utility of Intraoperative Allograft Vascular Inflow Measurements in Donation After Circulatory Death Liver Transplantation	9
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	9
Outcomes of liver transplantation in recipients with previous coronavirus disease 2019 infection	9
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients	9
Issue Information	9
Reply	9
Issue Information	9
Long‐term Outcomes of Stent Placement Inside the Bile Duct for Biliary Strictures After Living Donor Liver Transplantation	9

Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis	8
Erratum	8
Adverse effects of graft congestion and ameliorative effects of hepatocyte growth factor after liver transplantation in rats	8
Erratum	8
Issue Information	8
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	8
Financial burden in adults with chronic liver disease: A scoping review	8
Tobacco use, cirrhosis, and age are predictors of readiness to change and continued drinking following brief alcohol intervention in veterans	8
Transjugular intrahepatic portosystemic shunt for the patients on the liver transplant list	8
Issue Information	8
Issue Information ‐ Instructions to Authors	8
Issue Information	8
Incidence and risk factors for chronic rejection in pediatric liver transplantation	8
Introducing the History, Culture, and Liver Disease series	8
Issue Information ‐ Instructions to Authors	8
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	8
Domino liver transplantation: Expanding the liver donor pool to the pediatric recipient	8
Utilization of biomarkers for alcohol use in candidates for liver transplantation with alcohol-associated liver disease	7
Inequity in access to liver transplant care: Time to make the invisible visible	7
Letter to the Editor: Improved outcomes of ABO-incompatible living donor liver transplant with biologically related donors	7
	7
A Modified liver donor risk index for pediatric liver transplant recipients	7
Role of mentorship in the learning curve of robotic right lobe donor hepatectomy	7
Issue Information	7
Principles for simulating the organ allocation system	7
Portal vein complications and outcomes following pediatric liver transplantation: Data from the Society of Pediatric Liver Transplantation	7
Telemedicine in Hepatology: Current Applications and Future Directions	7
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	7
Issue Information ‐ Instructions to Authors	7
Immunosuppression protocols for emerging oncological indications in liver transplantation: A systematic review and pooled analysis	7
Differential aging trends among Liver Transplant candidates with and without hepatocellular carcinoma	7
	7
Letter to the Editor: Time for validating GEMA-Na in the United States for liver transplant waiting list prioritization	7
Pre-operative assessment of body composition and sarcopenia in multivisceral transplant candidates	7
Clinical outcomes in patients with unintended pregnancy after liver transplantation: A multicenter registry cohort study	7
Distal Gastroduodenal Arterial Inflow as a Salvage Strategy for Extensive Intraoperative Arterial Dissectıon in Living Donor Liver Transplantation	7
Introducing the Certificate of Added Qualification (CAQ) Corner	7
Incremental impact of organ allocation changes and machine perfusion technology on liver transplant waitlist and volumes	7
Cystatin C in decompensated cirrhosis: Shedding the excess baggage in clinical practice	7
	7
Outcomes of pediatric liver retransplantation candidates in the modern era: Strategies are needed to avoid waitlist mortality in the United States	7
Performance of race-neutral eGFR equations in patients with decompensated cirrhosis	7
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: Prevalence, noninvasive diagnosis, and burden on surgical outcomes	7
Circulating Tumor Cell–Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue‐Based Messenger RNA Profiling Into a Noninvasive Setting	7
Impact of the Kasai Procedure and the Length of Native Liver Survival Time on Outcomes of Liver Transplantation for Biliary Atresia	7
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	6
Reply: Improved outcomes of ABO incompatible living donor liver transplant with biologically related donor	6
Development and validation of MRI-PDFF cutoffs for living liver donor eligibility assessment	6
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	6
Extracorporeal membrane oxygenation for cardiopulmonary failure in organ donation: Assessing liver transplant outcomes	6
Splenic Artery Transposition for Hepatic Artery Reconstruction During Liver Transplantation: Is It the Best Choice for Adequate Arterial Inflow in Extraordinary Conditions?	6
Dealing With Multiple Bile Ducts in Living Donor Liver Transplantation: A Novel Technique Incorporating End‐to‐Side Biliary Anastomosis	6
The University of Southern California psychosocial checklist: A novel tool to remotely screen transplant candidates with alcohol-associated liver disease prior to hospital transfer	6
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	6
Does the introduction of the acuity circle policy change split liver transplantation practice?	6
PRO: Is the management of ACLF better in a liver-dedicated ICU?	6
Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study: Erratum	6
Salvaging the fatty liver for transplant: is short duration NMP enough?	6
The Motivations for Donation Among Potential Adolescent Living Donor Liver Transplantation Donors	6
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes	6
The learning curve for robotic living donor right hepatectomy: Analysis of outcomes in 2 specialized centers	6
Less is more: The use of single biodegradable stenting to treat biliary anastomotic strictures in pediatric liver transplantation	6
PRO: All patients should receive a palliative care consult during LT evaluation	6
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	6
Moving Forward in the Stratification of Cardiac Risk in Liver Transplantation Candidates	6
Estimating Glomerular Filtration Rate in Cirrhosis: A Variable Science That Needs Clinical Awareness	6
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transpla	6
Reply	6
Liver transplantation after ex vivo normothermic machine preservation without recooling the graft: A clinical series from a single center	6
The financial burden after liver transplantation is significant among commercially insured adults: A large US National Cohort	5
No Foul Play for Transjugular Intrahepatic Portosystemic Shunts in Liver Transplantation for Hepatocellular Carcinoma	5
Operational tolerance is not always permanent	5
Differences Between Infectious Disease Events in First Liver Transplant Versus Retransplantation in the Swiss Transplant Cohort Study	5
Issue Information	5
Treatment strategies for hepatic artery complications after pediatric liver transplantation: A systematic review	5
Issue Information ‐ Author Checklist	5
Letter to the Editor: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	5
Long‐term follow‐up of living liver donors	5
Reduction of Visceral Adiposity as a Predictor for Resolution of Nonalcoholic Fatty Liver in Potential Living Liver Donors	5
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	5
Challenging the Traditional Paradigm of Supply and Demand in Pediatric Liver Transplantation Through Nondirected Living Donation: A Case Series	5
Positron emission tomography myocardial perfusion imaging (PET MPI) findings predictive of post-liver transplant major adverse cardiac events	5
Compartmentalizing risk with sarcopenic obesity	5
Reply	5
Expanding Experience With Liver Transplantation in Acute Intermittent Porphyria	5
Surgical site infections are independently associated with the development of postoperative acute-on-chronic liver failure in liver cirrhosis	5
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	5
Reduced metabolic flexibility is a predictor of weight gain among liver transplant recipients	5
Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria	5
Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis	5
Posttransplant Hemophagocytic Lymphohistiocytosis in Pediatric Liver Transplant Recipients	5
Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation	5
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End‐Stage Liver Disease Scores <30	5
Issue Information ‐ Instructions to Authors	5
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study	5